Chris Bushe

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
    Chris Bushe
    Eli Lilly and Co Ltd, Basingstoke, University of Southampton, UK
    Br J Psychiatry Suppl 47:S67-71. 2004
  2. ncbi request reprint Association between atypical antipsychotic agents and type 2 diabetes: review of prospective clinical data
    Chris Bushe
    Eli Lilly and Co Ltd, Basingstoke, UK
    Br J Psychiatry Suppl 47:S87-93. 2004
  3. doi request reprint Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics
    Chris Bushe
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 22:56-62. 2008
  4. ncbi request reprint The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
    Chris Bushe
    Eli Lilly and Company Limited, Basingstoke, UK
    J Psychopharmacol 19:76-83. 2005
  5. doi request reprint A review of the association between antipsychotic use and hyperprolactinaemia
    Chris Bushe
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 22:46-55. 2008
  6. ncbi request reprint The role of lifestyle interventions and weight management in schizophrenia
    Chris Bushe
    Eli Lilly and Company Limited, Basingstoke, UK
    J Psychopharmacol 19:28-35. 2005
  7. ncbi request reprint Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics
    Chris Bushe
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 21:768-73. 2007

Detail Information

Publications7

  1. ncbi request reprint Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
    Chris Bushe
    Eli Lilly and Co Ltd, Basingstoke, University of Southampton, UK
    Br J Psychiatry Suppl 47:S67-71. 2004
    ..A number of studies have examined the prevalence of diabetes mellitus and impaired glucose tolerance in general populations and in those with schizophrenia and other forms of serious mental illness...
  2. ncbi request reprint Association between atypical antipsychotic agents and type 2 diabetes: review of prospective clinical data
    Chris Bushe
    Eli Lilly and Co Ltd, Basingstoke, UK
    Br J Psychiatry Suppl 47:S87-93. 2004
    ..Most evidence suggesting an association between schizophrenia, antipsychotic medications and diabetes has been based on retrospective studies not controlled for important confounders...
  3. doi request reprint Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics
    Chris Bushe
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 22:56-62. 2008
    ..Clinicians may wish to add prolactin measurement to the routine laboratory parameters currently measured for some antipsychotics and should be advised of the potential longer-term consequences of hidden hyperprolactinaemia...
  4. ncbi request reprint The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
    Chris Bushe
    Eli Lilly and Company Limited, Basingstoke, UK
    J Psychopharmacol 19:76-83. 2005
    ....
  5. doi request reprint A review of the association between antipsychotic use and hyperprolactinaemia
    Chris Bushe
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 22:46-55. 2008
    ..Significant rates of hyperprolactinaemia of lesser severity and more transience have also been reported in association with other atypical antipsychotics...
  6. ncbi request reprint The role of lifestyle interventions and weight management in schizophrenia
    Chris Bushe
    Eli Lilly and Company Limited, Basingstoke, UK
    J Psychopharmacol 19:28-35. 2005
    ..Weight management and lifestyle advice should be routinely offered to all schizophrenia subjects...
  7. ncbi request reprint Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics
    Chris Bushe
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 21:768-73. 2007
    ..Clinicians may be helped by the reporting of such categorical data from clinical trials in addition to mean cohort values of prolactin. Long-term hyperprolactinaemia may be associated with clinical sequeLae in some patients...